RSS
|
Login
|
Register
Home
News
Latest News
People Moves
Business Briefs
Newsletters
Features
Features
Surveys
Reprints
Editorial Calendar
Issue Archive
Events
MM&M Awards
Webcasts
Podcasts
Whitepapers
Directories
PMD
MM&M Service Directory
Agency Gallery
Direct Marketing Showcase
Medical Education Review
About Us
Subscriber Services
Contact Us
Media Information
Editorial Advisory Board
Jobs
Drug Info
New Drug Dossier
Drug Database
Subscribe
Order Now
Subscriber Services
Newsletters
Marketing Research Articles
Street taps Epocrates for research
Marc Iskowitz
March 01, 2008
The research arm of investment banking firm Goldman Sachs will look to promote Epocrates' marketing research services.
AMA, states continue data mining alternatives
Marc Iskowitz
March 01, 2008
While data mining laws are mired in court, alternatives are helping physicians control rep encounters and help states manage costs.
Vantage Point
Richard Vanderveer
March 01, 2008
As this is being written, word came across that IMS, that venerable organization of pharma marketing research, was about to lay off 10% of its work force.
Vantage Point
Richard Vanderveer
February 01, 2008
A document recently crossed my desk that was so seminal I needed to share it with my colleagues through this column.
Federal judge rejects ME prescription data law
Marc Iskowitz
February 01, 2008
A Maine law that would have limited access by medical data companies to doctors' prescription information was reversed on constitutional grounds.
Tough business climate roils IMS
Marc Iskowitz
February 01, 2008
IMS Health said it intends to lay off 10% of its workforce, or as many as 760 employees worldwide.
Vantage Point
Richard Vanderveer
January 01, 2008
In December we predicted a wild ride in 2008 for pharmaceutical marketing research.
Analytics pros more than just 'quants,' says study
Marc Iskowitz
January 01, 2008
Market research departments of a number of life science companies incorporate analytics functions, either partially or fully, a study shows.
New Web 2.0 metric not the old ROI
Marc Iskowitz
January 01, 2008
As pharma begins incorporating Web 2.0 tools in their marketing, many are unsure how to assess them.
Vantage Point
Richard Vanderveer
December 01, 2007
For pharmaceutical marketing research, I believe that 2007 constituted a tipping point.
« Previous
Next »
Most Popular
Most Emailed
Most Recent
Pharmalot's Silverman moves to FDC Reports
MM&M All-Stars Agency of the Year: Digitas Health
DDMAC warning and untitled letters in 2008 total 21
MM&M All-Stars Company of the Year: Johnson & Johnson
AAFP launches consumer site
HealthCentral visitors more likely to request scripts from docs: Manhattan Research
MM&M All-Stars Large Pharma Marketing Team: Crestor
US healthcare spend slows on generic growth, says journal
MM&M All-Stars Small Marketing Team: Keppra
MM&M All-Stars Media Brand: Everyday Health
Rep. Waxman: DTC ban a priority
AAFP launches consumer site
New study results strengthen hormone therapy, cancer link
PhRMA tweaks DTC guidelines
BMS launches TV awareness ads in Mandarin
BMS downsizes workforce 10%
CommonHealth combines Ferguson, Noesis
Saatchi Consumer absorbs spin-off Glow Worm amid downturn
Pharmalot's Silverman moves to FDC Reports
FDA raps tiny text in Abbott ad
AAFP launches consumer site
HealthCentral visitors more likely to request scripts from docs: Manhattan Research
US healthcare spend slows on generic growth, says journal
Pharmalot's Silverman moves to FDC Reports
DDMAC warning and untitled letters in 2008 total 21
NME approvals up a tic in 2008
FDA raps tiny text in Abbott ad
GSK to end corporate political contributions
Dingell to head up healthcare policy on key House committee
Industry coalition wary of potential FDA chief candidates
Popular Tags
Advertising
Agency
Approval
Business
Clinical trial
Consumer
CRM
Digital
Direct marketing
Direct to consumer (DTC)
Direct to patient (DTP)
FDA
Government
Legal
Marketing & Communications
Media
Medical Journal
Online
Pharmaceutical
Promotion
Regulatory
Research & Development
Television
Trend
Warning